For past Congresses, use the Browse menu.
HR 3839
118th Congress • 2023–2025 (Ended)

To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.


Organizations below reported lobbying activity on this bill. Expand to view filing details.
Loading filings…